Literature DB >> 32503849

Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.

Jérôme Avouac1, Paolo Airó2, Nicolas Carlier3, Marco Matucci-Cerinic4, Yannick Allanore5.   

Abstract

Entities:  

Keywords:  inflammation; rituximab; scleroderma; systemic

Mesh：

Substances：

Year:  2020        PMID： 32503849     DOI： 10.1136/annrheumdis-2020-217864

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  33 in total

1.  Impact of COVID-19 on outpatient therapy with iloprost for systemic sclerosis digital ulcers.

Authors:  Francesca Crisafulli; Maria-Grazia Lazzaroni; Stefania Zingarelli; Mara Rossi; Angela Tincani; Franco Franceschini; Paolo Airò
Journal:  J Scleroderma Relat Disord       Date:  2020-09-10

2.  Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication.

Authors:  Davide Mohammad Reza Beigi; Greta Pellegrino; Marius Cadar; Ilaria Bisconti; Francesca Romana Di Ciommo; Katia Stefanantoni; Fabrizio Conti; Valeria Riccieri
Journal:  Open Access Rheumatol       Date:  2022-07-11

3.  COVID-19, rheumatic diseases and immune dysregulation-a perspective.

Authors:  Shahna Tariq; Charmaine Van Eeden; Jan Willem Cohen Tervaert; Mohammed S Osman
Journal:  Clin Rheumatol       Date:  2021-01-07       Impact factor: 2.980

4.  COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review.

Authors:  Jessica M Jones; Aiman J Faruqi; James K Sullivan; Cassandra Calabrese; Leonard H Calabrese
Journal:  Pathog Immun       Date:  2021-05-14

5.  Low symptomatic COVID-19 in an elderly patient with follicular lymphoma treated with rituximab-based immunotherapy: A case report.

Authors:  Stanisław Łącki; Kinga Wyżgolik; Michał Nicze; Sylwia Georgiew-Nadziakiewicz; Jerzy Chudek; Kamil Wdowiak
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

6.  Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery.

Authors:  Evangéline Clark; Philippe Guilpain; Ionut Laurentiu Filip; Nathalie Pansu; Clément Le Bihan; Guillaume Cartron; Emmanuelle Tchernonog; Camille Roubille; David Morquin; Alain Makinson; Edouard Tuaillon; Vincent Le Moing
Journal:  Br J Haematol       Date:  2020-07-16       Impact factor: 8.615

7.  Covid-19 overlapping with systemic sclerosis.

Authors:  Rachel Zerbini Mariano; Ana Paula Toledo Del Rio; Fabiano Reis
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-21       Impact factor: 1.581

8.  Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis.

Authors:  Nicoletta Del Papa; Gianluca Sambataro; Antonina Minniti; Wanda Maglione; Francesca Pignataro; Antonella Caminati; Sergio Harari; Domenico Sambataro; Claudio Vitali; Roberto Felice Caporali
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-09-24       Impact factor: 5.346

Review 9.  The Care of the Leukemic Patients in Times of SARS-CoV-2.

Authors:  Nabin Raj Karki; Thuy Le; Jorge Cortes
Journal:  Curr Oncol Rep       Date:  2021-08-03       Impact factor: 5.075

Review 10.  Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.

Authors:  Amir Mohammad Beyzaee; Ghasem Rahmatpour Rokni; Anant Patil; Mohamad Goldust
Journal:  Dermatol Ther       Date:  2020-10-20       Impact factor: 3.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.